Psychedelic Renaissance: Clinical Health Justice, Patient Safety, and Equity Need to Be Put First - Jacques Ambrose; J.S. Zabinski (Psychiatric News, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Psychedelics Legislation Gains Momentum - Terri D’Arrigo (Psychiatric News, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Assessment of the acute effects of 2C-B vs psilocybin on subjective experience, mood and cognition - Mallaroni P; Mason NL; Reckweg JT; Paci R; Ritscher S; Toennes SW; Theunissen EL; Kuypers KP; Ramaekers JG. (bioRxiv, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Psychedelics for the Neuropsychiatric Symptoms of Alzheimer's disease - Ashish Sarangi; Omotola Akinkunmi (American Journal of Geriatric Psychiatry, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Considerations in assessing the abuse potential of psychedelics during drug development. - Calderon SN; Bonson KR; Reissig CJ; Lloyd JM; Galati S; Chiapperino D (Neuropharmacology, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Psilocybin-assisted therapy improves psycho-social-spiritual well-being in cancer patients. - Shnayder S; Ameli R; Sinaii N; Berger A; Agrawal M (Journal of affective disorders, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Psychotherapists' openness to engage their patients in Psilocybin-Assisted Therapy for mental health treatment. - Meir P; Taylor L; Soares JC; Meyer TD (Journal of affective disorders, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

The History, Legalization and Potentials of Psilocybin-Assisted Psychotherapy - Jeffery Heilman (Journal of Scientific Exploration, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Examining associations between MDMA/ecstasy and classic psychedelic use and impairments in social functioning in a U.S. adult sample. - Jones G; Lipson J; Wang E (Scientific reports, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

The therapeutic potential of psychedelics: the European regulatory perspective - Florence Butlen-Ducuing; Drummond E-Wen McCulloch; Marion Haberkamp; Taina Mattila; Ewa Bałkowiec-Iskra; Georgios Aislaitner; П. В. Балабанов; Johan Lundberg; Dea Siggaard Stenbæk; André Elferink; Gitte M. Knudsen; Steffen Thirstrup (The Lancet, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Hofmann vs. Paracelsus: Do Psychedelics Defy the Basics of Toxicology?-A Systematic Review of the Main Ergolamines, Simple Tryptamines, and Phenylethylamines. - Henríquez-Hernández LA; Rojas-Hernández J; Quintana-Hernández DJ; Borkel LF (Toxics, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Wirkt Psilocybin nachhaltig antidepressiv? - Lea J. Mertens (InFo Neurologie + Psychiatrie, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

More on psilocybin - Aryan Sarparast (Current Psychiatry, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Novel antidepressant drugs: Beyond monoamine targets. - Gonda X; Dome P; Neill JC; Tarazi FI (CNS spectrums, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Psychedelic therapy for depressive symptoms: A systematic review and meta-analysis. - Ko K; Kopra EI; Cleare AJ; Rucker JJ (Journal of affective disorders, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Matrix-assisted laser-desorption/ionization-mass spectrometric imaging of psilocybin and its analogues in psychedelic mushrooms using a cesium chloride-coated target plate. - Wang H; Wang Y (Analytical and bioanalytical chemistry, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Subacute effects of a single dose of psilocybin on biomarkers of inflammation in healthy humans: An open-label preliminary investigation. - Burmester DR; Madsen MK; Szabo A; Aripaka SS; Stenbæk DS; Frokjaer VG; Elfving B; Mikkelsen JD; Knudsen GM; Fisher PM (Comprehensive psychoneuroendocrinology, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

5-HT2ARs Mediate Therapeutic Behavioral Effects of Psychedelic Tryptamines. - Cameron LP; Patel SD; Vargas MV; Barragan EV; Saeger HN; Warren HT; Chow WL; Gray JA; Olson DE (ACS chemical neuroscience, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Single-dose psilocybin-assisted therapy in major depressive disorder: A placebo-controlled, double-blind, randomised clinical trial. - von Rotz R; Schindowski EM; Jungwirth J; Schuldt A; Rieser NM; Zahoranszky K; Seifritz E; Nowak A; Nowak P; Jäncke L; Preller KH; Vollenweider FX (EClinicalMedicine, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Corrigendum to 'Single-dose psilocybin-assisted therapy in major depressive disorder: a placebo-controlled, double-blind, randomised clinical trial'. - von Rotz R; Schindowski EM; Jungwirth J; Schuldt A; Rieser NM; Zahoranszky K; Seifritz E; Nowak A; Nowak P; Jäncke L; Preller KH; Vollenweider FX (EClinicalMedicine, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Psilocybin therapy for depression. A good trip? - Rucker JJ (Journal of mental health (Abingdon, England), 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Plant Medicine Healing! Discovering the Roots of Psychedelic-Assisted Therapy in Mental Health - Jennings Hernandez (Advances in Research, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

SV2A Marker of Synaptogenesis in a Clinical Trial of Psilocybin for Depression - Washington University School of Medicine (ClinicalTrials.gov, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Medications for the Treatment of Alcohol Dependence-Current State of Knowledge and Future Perspectives from a Public Health Perspective. - Stokłosa I; Więckiewicz G; Stokłosa M; Piegza M; Pudlo R; Gorczyca P (International journal of environmental research and public health, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Group format psychedelic-assisted therapy interventions: Observations and impressions from the HOPE trial - Benjamin R. Lewis; Kevin Byrne; John Hendrick; Eric L. Garland; Paul Thielking; Anna C. Beck (Journal of Psychedelic Studies, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Therapeutic potential of psilocybin: a promising agent in treating major depressive disorder - Dragana Marković; Eleonora Čapelja (AIDASCO Reviews, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Pilot Trial of Visual Healing®, a Nature-themed Virtual Immersive Experience, to Optimize Set and Setting in Psilocybin-assisted Therapy for Alcohol Use Disorder - Keith Heinzerling (ClinicalTrials.gov, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Is psilocybin an effective antidepressant and what is its Mechanism of action? - Mann JJ (Cell reports. Medicine, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Recruitment discrimination of lifetime classic psychedelic users is unjustified: Evidence from employees' motivation-based workplace absenteeism - Benjamin A. Korman (Journal of Psychedelic Studies, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Psychedelic integration challenges: Participant experiences after a psilocybin truffle retreat in the Netherlands - Anna Lutkajtis; Jules Evans (Journal of Psychedelic Studies, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

On blinding and suicide risk in a recent trial of psilocybin-assisted therapy for treatment-resistant depression. - Gukasyan N (Med (New York, N.Y.), 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Indigenous-Amazonian Traditional Medicine's Usage of the Tobacco Plant: A Transdisciplinary Ethnopsychological Mixed-Methods Case Study. - Berlowitz I; García Torres E; Maake C; Wolf U; Martin-Soelch C (Plants (Basel, Switzerland), 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

The Bright Side of Psychedelics: Latest Advances and Challenges in Neuropharmacology. - Mastinu A; Anyanwu M; Carone M; Abate G; Bonini SA; Peron G; Tirelli E; Pucci M; Ribaudo G; Oselladore E; Premoli M; Gianoncelli A; et al. (International journal of molecular sciences, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Conformational Landscape and Hydrogen Bonding Pattern of Psilocin: Computational Insights - Bhadoria Poonam; Ramanathan Venkatnarayan (ChemistrySelect, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Acute psilocybin enhances cognitive flexibility in rats. - Torrado Pacheco A; Olson RJ; Garza G; Moghaddam B (bioRxiv: the preprint server for biology, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Healing at death’s door: one patient’s mystical experience with psilocybin - Houman Farzin (International Journal of Whole Person Care, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

The Therapeutic Potential of Psilocybin in Alcohol Use Disorder Recovery: A Literature Review - Kaden Venugopal; Nefissa Bedri (Undergraduate Research in Natural and Clinical Science and Technology (URNCST) Journal, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Et psykoanalytisk og et postmoderne perspektiv på selv/egoopløsning i en psykedelisk kontekst - Andersen S. (PsyArXiv, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Et psykoanalytisk og et postmoderne perspektiv på selv/egoopløsning i en psykedelisk kontekst - Sidsel Andersen (PsyArXiv, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Cognitive liberty and the constitutionality of criminalising psilocybin mushrooms in South Africa - Sebastian William Foster (South African Journal on Human Rights, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Psilocybin in the treatment of generalized anxiety disorder (GAD), alcoholism and smoking: a literature review - Fabiano F. da Silva; Thaysa Adriane Costa Bernardo; Johny Ricarte das Silva Rodrigues; Pierre Teodósio Félix (IJS - International Journal of Sciences, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Psilocin esters - An investigation of synthetic feasibility, chemical, and metabolic stability - Eklund; Julia (Zenodo (CERN European Organization for Nuclear Research), 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

In Search of: A Federal Safe Harbor for State Legalization of Psilocybin - Tucker; Kathryn L.; Martinez; Holly; Morris; Ebony (Lewis & Clark Law Review, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Acute neurovascular effects of psilocybin administration in healthy humans: Implications for cerebral blood flow measurements using arterial spin labelling - Klaus Richter Larsen; Ulrich Lindberg; Brice Ozenne; Drummond E-Wen McCulloch; Sophia Armand; M. Madsen; Annette Johansen; Dea Siggaard Stenbæk; Gitte M. Knudsen; Patrick M. Fisher (Neuroscience Applied, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Psilocybin rescues depressive phenotype and modulates serotonin-2A and glucocorticoid receptor mRNA expression in brain cortex of a stress animal model - Ines Erkizia-Santamaría; Guadalupe Rivero; Igor Horrillo; J. Javier Meana; Jorge E. Ortega (Neuroscience Applied, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

The safety and efficacy of COMP360 psilocybin therapy in treatment-resistant depression: results from a long-term observational follow-up study - Guy M. Goodwin; Lindsey Marwood; S. Mistry; Anna Nowakowska; Zainib Shabir; H. Clifton Simmons; E.K. Teoh; Jeng-Yu Tsai; E. Malievskaia (Neuroscience Applied, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Effect of co-administration of low doses of psilocybin and mGluR2/3 antagonist LY341495 in chronic restraint stress model of depression - Agata Machaczka; Jane Turek; Dorota Bederska-Łojewska; Bartłomiej Pochwat; Łukasz Gąsior; Bernadeta Szewczyk; Andrzej Pilc (Neuroscience Applied, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Behavioral effects of a 14-day repeated treatment with psilocybin at a low non-psychedelic dose: a preliminary study in C57BL/6J mice - Sofia Nasini; Martina Colognesi; Sara Tidei; Sara De Martin; Marco Banzato; Andrea Mattarei; Franco Folli; P. Marco; Paolo L. Manfredi; Stefano Comai (Neuroscience Applied, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Withdrawal of antidepressants does not impact the efficacy of COMP360 psilocybin therapy: results from a phase IIb randomised controlled trial - Guy M. Goodwin; Megan Croal; J. Chai-Rees; Lindsey Marwood; S. Mistry; Anna Nowakowska; H. Clifton Simmons; Jeng-Yu Tsai (Neuroscience Applied, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Change in whole blood BDNF after escitalopram or psilocybin intervention in patients with depression and healthy controls - Miriam L. Navarro; Alberte Wollesen Breum; Annette Johansen; Brice Ozenne; Vibe G. Frøkjær; Gitte M. Knudsen (Neuroscience Applied, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

A multi-metric evaluation of psilocybin effects on functional brain entropy in healthy volunteers - Drummond E-Wen McCulloch; Anders Smærup Olsen; Dea Siggaard Stenbæk; Sophia Armand; M. Madsen; Gitte M. Knudsen; Patrick M. Fisher (Neuroscience Applied, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Investigating changes in EEG entropy rate in response to psilocybin - a comparison of lempel ziv and state-space entropy rate measures - M. Nikolič; P. Mediano; Tom Froese; Tomáš Páleníček (Neuroscience Applied, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Visualizing drug actions on dendrites: psilocybin and other classic psychedelics - Shao Ling-Xiao; Liao Clara; Gregg Ian; Davoudian Pasha A; Savalia Neil K; Delagarza Kristina; Kwan Alex C. (Biophotonics Congress: Optics in the Life Sciences 2023 (OMA, NTM, BODA, OMP, BRAIN), 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Italian psychedelic therapies of the past century: An historical overview - Adriana D’Arienzo; Giorgio Samorini (Drug Science Policy and Law, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Going on Trial: Serotonin drug; psilocybin phase 2; placebo response data - Peter Hess (The Transmitter, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Company on brink takes psilocybin to trial for fragile X syndrome - Peter Hess (The Transmitter, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Therapeutic mechanism of psilocybin in the treatment of depression and other psychiatric disorders. - O. Shahar; A. Botvinik; T. Lifschytz; B. Lerer (Neuroscience Applied, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Going on Trial: Arbaclofen reboot; cell implants; psilocybin microdoses - Peter Hess (The Transmitter, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Psychedelic-Assisted Therapy and Meditative Experience as Factors of Personal Change - Nadiia Omelchenko; Anton Kurapov (Bulletin of Taras Shevchenko National University of Kyiv Psychology, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Psychedelic Drug Therapy for Mental Disorders? - John R. Rossiter (Open Journal of Medical Psychology, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

The right to privacy in the decriminalisation of psilocybin mushrooms in South Africa - Sebastian William Foster (Law Democracy & Development, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Psilocybin as a treatment for anorexia nervosa: 6-week and 3-month follow-up results - Hannah Douglass; Merle Spriggs; Kate Godfrey; Jennifer L. Danby; Francisco Magalhães; Kirsty L. Alderton; Liane Macdonald; Stephanie Archer; Tim Read; Adèle Lafrance; Dasha Nicholls; David Erritzøe; et al. (Neuroscience Applied, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

A roadmap for psychedelic pharmacy in Canada: A proposed policy and operations approach for controlled access to select psychedelics for treatment of mental illness - Jaden Brandt (Drug Science Policy and Law, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Case report: Prolonged amelioration of mild red-green color vision deficiency following psilocybin mushroom use - Brian S. Barnett; Noah Wiles Sweat; Peter S. Hendricks (Drug Science Policy and Law, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Predictors of Psychedelic Experience: A Thematic Analysis. - McCartney AM; McGovern HT; De Foe A (Journal of psychoactive drugs, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Electrophysiological study of visual and auditory processing in psilocin-induced hallucinations: exploring evoked potentials and 5-HT2A receptor involvement - Vejmola Č.; Hubený J.; Koudelka V.; Griškova-Bulanova I.; Páleníček T. (Neuroscience Applied, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Linkages between Psychedelics and Meditation in a Population-Based Sample in the United States. - Simonsson O; Goldberg SB (Journal of psychoactive drugs, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

The Psychedelic Renaissance in Clinical Research: A Bibliometric Analysis of Three Decades of Human Studies with Psychedelics. - Hadar A; David J; Shalit N; Roseman L; Gross R; Sessa B; Lev-Ran S (Journal of psychoactive drugs, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Knowledge, Perceptions, and Use of Psychedelics among Individuals with Fibromyalgia. - Glynos NG; Pierce J; Davis AK; McAfee J; Boehnke KF (Journal of psychoactive drugs, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

The Use of Psilocybin in the Treatment of Psychiatric Disorders with Attention to Relative Safety Profile: A Systematic Review. - Hodge AT; Sukpraprut-Braaten S; Narlesky M; Strayhan RC (Journal of psychoactive drugs, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

How Important Is a Guide Who Has Taken Psilocybin in Psilocybin-Assisted Therapy for Depression? - Earleywine M; Low F; Altman BR; De Leo J (Journal of psychoactive drugs, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Sustained effects of single doses of classical psychedelics in humans. - Knudsen GM (Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

The Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force Report: Serotonergic Psychedelic Treatments for Major Depressive Disorder. - Rosenblat JD; Husain MI; Lee Y; McIntyre RS; Mansur RB; Castle D; Offman H; Parikh SV; Frey BN; Schaffer A; Greenway KT; Garel N; et al. (Canadian journal of psychiatry. Revue canadienne de psychiatrie, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Towards an understanding of psychedelic-induced neuroplasticity. - Calder AE; Hasler G (Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

The Safety and Efficacy of Psychedelic-Assisted Therapies for Older Adults: Knowns and Unknowns. - Johnston CB; Mangini M; Grob C; Anderson B (The American journal of geriatric psychiatry: official journal of the American Association for Geriatric Psychiatry, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Mescaline: The forgotten psychedelic. - Vamvakopoulou IA; Narine KAD; Campbell I; Dyck JRB; Nutt DJ (Neuropharmacology, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Race and ethnicity moderate the associations between lifetime psychedelic use (MDMA/ecstasy and psilocybin) and major depressive episodes. - Jones GM (Journal of psychopharmacology (Oxford, England), 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Psilocin - The “real deal” or an extraction byproduct - Gutman Ori; Tenne Dana; Bretler Uriel (Journal of Forensic Sciences, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Body mass index (BMI) does not predict responses to psilocybin. - Spriggs MJ; Giribaldi B; Lyons T; Rosas FE; Kärtner LS; Buchborn T; Douglass HM; Roseman L; Timmermann C; Erritzoe D; Nutt DJ; Carhart-Harris RL (Journal of psychopharmacology (Oxford, England), 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Should we be leery of being Leary? Concerns about psychedelic use by psychedelic researchers. - Kious B; Schwartz Z; Lewis B (Journal of psychopharmacology (Oxford, England), 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Changes in music-evoked emotion and ventral striatal functional connectivity after psilocybin therapy for depression. - Shukuroglou M; Roseman L; Wall M; Nutt D; Kaelen M; Carhart-Harris R (Journal of psychopharmacology (Oxford, England), 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Psilocybin mitigates the cognitive deficits observed in a rat model of Fragile X syndrome. - Buzzelli V; Carbone E; Manduca A; Schiavi S; Feo A; Perederiy JV; Ambert KH; Hausman M; Trezza V (Psychopharmacology, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Psychedelic Drug Legislative Reform and Legalization in the US. - Siegel JS; Daily JE; Perry DA; Nicol GE (JAMA psychiatry, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Risks and benefits of psilocybin use in people with bipolar disorder: An international web-based survey on experiences of 'magic mushroom' consumption. - Morton E; Sakai K; Ashtari A; Pleet M; Michalak EE; Woolley J (Journal of psychopharmacology (Oxford, England), 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Probing the antidepressant potential of psilocybin: integrating insight from human research and animal models towards an understanding of neural circuit mechanisms. - Meccia J; Lopez J; Bagot RC (Psychopharmacology, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Psychedelic drug abuse potential assessment for new drug applications and controlled substance scheduling: A United States perspective. - Henningfield JE; Ashworth J; Heal DJ; Smith SL (Journal of psychopharmacology (Oxford, England), 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Among psychedelic-experienced users, only past use of psilocybin reliably predicts nature relatedness. - Forstmann M; Kettner HS; Sagioglou C; Irvine A; Gandy S; Carhart-Harris RL; Luke D (Journal of psychopharmacology (Oxford, England), 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Psilocybin in Palliative Care: An Update. - Whinkin E; Opalka M; Watters C; Jaffe A; Aggarwal S (Current geriatrics reports, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Functional MRI markers for treatment-resistant depression: Insights and challenges. - Kotoula V; Evans JW; Punturieri C; Johnson SC; Zarate CA (Progress in brain research, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Next generation antidepressants with novel mechanisms for treatment resistant depression. - Chen MH; Tu PC; Su TP (Progress in brain research, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

The Resurgence of Hallucinogen Drugs in Clinical Research. - Rivera-García MT; Cruz SL (Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Evaluation of Sensorimotor Gating Deficits in Mice Through Prepulse Inhibition (PPI) of the Startle Response. - Unzueta-Larrinaga P; Urigüen L (Methods in molecular biology (Clifton, N.J.), 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Biological embedding of early trauma: the role of higher prefrontal synaptic strength. - Tamman AJF; Jiang L; Averill CL; Mason GF; Averill LA; Abdallah CG (European journal of psychotraumatology, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

UNCOVERING THE UNTAPPED POTENTIAL OF PSILOCYBIN THERAPY IN ALLEVIATING CANCER-RELATED DEPRESSION: AN URGENT CALL TO RE-EVALUATE TREATMENT STRATEGIES. - Ahmed H; Mushahid H; Arshad T (Psychiatria Danubina, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Efficacy and Safety of Psychedelics in Treating Anxiety Disorders. - Feulner L; Sermchaiwong T; Rodland N; Galarneau D (Ochsner journal, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Past Is Prologue: Ethical Issues in Pediatric Psychedelics Research and Treatment. - Edelsohn GA; Sisti D (Perspectives in biology and medicine, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

When art therapy went chemical: Alfred Bader, pharmacology, and art brut, c.1950-1970s. - Martinovic J (Historia, ciencias, saude--Manguinhos, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Classic psychedelics do not affect T cell and monocyte immune responses. - Rudin D; Areesanan A; Liechti ME; Gründemann C (Frontiers in psychiatry, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Therapeutic effect of psilocybin in addiction: A systematic review. - van der Meer PB; Fuentes JJ; Kaptein AA; Schoones JW; de Waal MM; Goudriaan AE; Kramers K; Schellekens A; Somers M; Bossong MG; Batalla A (Frontiers in psychiatry, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Cannabis-assisted psychotherapy for complex dissociative posttraumatic stress disorder: A case report. - Ragnhildstveit A; Kaiyo M; Snyder MB; Jackson LK; Lopez A; Mayo C; Miranda AC; August RJ; Seli P; Robison R; Averill LA (Frontiers in psychiatry, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Rearing behaviour in the mouse behavioural pattern monitor distinguishes the effects of psychedelics from those of lisuride and TBG. - Chen Y; Liu J; Yao Y; Yan H; Su R (Frontiers in pharmacology, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

The Effectiveness of Microdosed Psilocybin in the Treatment of Neuropsychiatric Lyme Disease: A Case Study. - Kinderlehrer DA (International medical case reports journal, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Editorial: What is up with psychedelics anyway? - Lewis CR; McMurray M; Mennenga SE; Helms Tillery S (Frontiers in neuroscience, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Exploring psilocybin-assisted psychotherapy in the treatment of methamphetamine use disorder. - Brett J; Knock E; Korthuis PT; Liknaitzky P; Murnane KS; Nicholas CR; Patterson JC; Stauffer CS (Frontiers in psychiatry, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Corrigendum: Three naturally-occurring psychedelics and their significance in the treatment of mental health disorders. - Vorobyeva N; Kozlova AA (Frontiers in pharmacology, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Magic Mushroom Use: A Qualitative Interview Study of Post-Trip Impacts and Strategies for Optimizing Experiences. - Shaw L; Rea K; Lachowsky NJ; Roth EA (Journal of psychoactive drugs, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Validation of a French Version of the Mystical Experience Questionnaire with Retrospective Reports of the Most Significant Psychedelic Experience among French Users. - Fauvel B; Kangaslampi S; Strika-Bruneau L; Roméo B; Piolino P (Journal of psychoactive drugs, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Seeking the Psilocybiome: Psychedelics meet the microbiota-gut-brain axis. - Kelly JR; Clarke G; Harkin A; Corr SC; Galvin S; Pradeep V; Cryan JF; O'Keane V; Dinan TG (International journal of clinical and health psychology: IJCHP, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

The Impact of Psilocybin on Patients Experiencing Psychiatric Symptoms: A Systematic Review of Randomized Clinical Trials. - IsHak WW; Garcia P; Pearl R; Dang J; William C; Totlani J; Danovitch I (Innovations in clinical neuroscience, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Psychedelics, entropic brain theory, and the taxonomy of conscious states: a summary of debates and perspectives. - Rankaduwa S; Owen AM (Neuroscience of consciousness, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Use of Selective Alternative Therapies for Treatment of OCD. - Khan I; Jaura TA; Tukruna A; Arif A; Tebha SS; Nasir S; Mukherjee D; Masroor N; Yosufi A (Neuropsychiatric disease and treatment, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Psychedelic-induced mystical experiences: An interdisciplinary discussion and critique. - Mosurinjohn S; Roseman L; Girn M (Frontiers in psychiatry, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Mini-review: The neurobiology of treating substance use disorders with classical psychedelics. - Urban MM; Stingl MR; Meinhardt MW (Frontiers in neuroscience, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Safety, tolerability, and clinical and neural effects of single-dose psilocybin in obsessive-compulsive disorder: protocol for a randomized, double-blind, placebo-controlled, non-crossover trial. - Ching THW; Grazioplene R; Bohner C; Kichuk SA; DePalmer G; D'Amico E; Eilbott J; Jankovsky A; Burke M; Hokanson J; Martins B; Witherow C; et al. (Frontiers in psychiatry, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Empirically validated theoretical analysis of visual-spatial perception under change of nervous system arousal. - Purohit P; Dutta P; Roy PK (Frontiers in computational neuroscience, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Editorial: Appropriateness and safety of using cannabinoid and psychedelic medicines as treatments for psychiatric disorders. - Blest-Hopley G; Amit BH; O'Neill A; Ruffell SGD (Frontiers in psychiatry, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Henri Michaux's program for the psychedelic humanities. - Davis O (Frontiers in psychology, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Acute psilocybin increased cortical activities in rats. - Liu J; Wang Y; Xia K; Wu J; Zheng D; Cai A; Yan H; Su R (Frontiers in neuroscience, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

The psychedelic afterglow phenomenon: a systematic review of subacute effects of classic serotonergic psychedelics. - Evens R; Schmidt ME; Majić T; Schmidt TT (Therapeutic advances in psychopharmacology, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

A case-study evaluation of the "Copenhagen Music Program" for psilocybin-assisted therapy. - Ratkovic G; Sosteric M; Sosteric T (Frontiers in psychology, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Systematic review and rationale of using psychedelics in the treatment of cannabis use disorder. - Phan AN; Terry GE (Frontiers in psychiatry, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Changes in synaptic markers after administration of ketamine or psychedelics: a systematic scoping review. - Zhornitsky S; Oliva HNP; Jayne LA; Allsop ASA; Kaye AP; Potenza MN; Angarita GA (Frontiers in psychiatry, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Medical student attitudes and perceptions of psychedelic-assisted therapies. - Li I; Fong R; Hagen M; Tabaac B (Frontiers in psychiatry, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Case report: Psychedelic-induced seizures captured by intracranial electrocorticography. - Blond BN; Schindler EAD (Frontiers in neurology, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Psychedelic Assisted Psychotherapy preparing your target using psychohistoriography: a Jamaican perspective. - De La Haye W; Walcott G; Eaton J; Beckford J; Greene J (Frontiers in psychiatry, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Psychedelic Microdosing, Mindfulness, and Anxiety: A Cross-Sectional Mediation Study. - Hartong V; van Emmerik A (Journal of psychoactive drugs, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

What is the progress of experimental drug development for fibromyalgia? - Lawson K (Expert opinion on investigational drugs, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Serotonin 5-HT receptor agonism and valvular heart disease: implications for the development of psilocybin and related agents. - McIntyre RS (Expert opinion on drug safety, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Is the psychedelic experience an essential aspect of the therapeutic effect of serotonergic psychedelics? Conceptual, discovery, development and implementation implications for psilocybin and related agents. - McIntyre RS (Expert opinion on drug safety, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Adapting psychedelic medicine for headache and chronic pain disorders. - Schindler EAD; Hendricks PS (Expert review of neurotherapeutics, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Assessing potential of psilocybin for depressive disorders. - Kozak Z; Johnson MW; Aaronson ST (Expert opinion on investigational drugs, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Altered states of leadership: mindfulness meditation, psychedelic use, and leadership development. - Simonsson O; Stenfors CUD; Goldberg SB; Hendricks PS; Osika W (Frontiers in psychology, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Psychoactive substance use in patients diagnosed with attention-deficit/hyperactivity disorder: an exploratory study. - Więckiewicz G; Stokłosa I; Stokłosa M; Więckiewicz W; Gorczyca P; Gondek TM (Frontiers in psychiatry, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Slouching towards engagement: interactions between people using psychedelics naturalistically and their healthcare providers. - Boehnke KF; Cox K; Weston C; Herberholz M; Glynos N; Kolbman N; Fields CW; Barron J; Kruger DJ (Frontiers in psychiatry, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Persons With Spinal Cord Injury Report Peripherally Dominant Serotonin-Like Syndrome After Use of Serotonergic Psychedelics. - Abrams SK; Rabinovitch BS; Zafar R; Aziz AS; Cherup NP; McMillan DW; Nielson JL; Lewis EC (Neurotrauma reports, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Race and ethnicity moderate the associations between lifetime psilocybin use and crime arrests. - Jones G; Al-Suwaidi M; Castro-Ramirez F; McGuire TC; Mair P; Nock MK (Frontiers in psychiatry, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

The Association of Classic Serotonergic Psychedelic Use and Intention of Future Use with Nature Relatedness. - Longo MSC; Bienemann B; Multedo M; Negreiros MA; Schenberg E; Mograbi DC (Journal of psychoactive drugs, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Scoping Review of Experiential Measures from Psychedelic Research and Clinical Trials. - Herrmann Z; Earleywine M; De Leo J; Slabaugh S; Kenny T; Rush AJ (Journal of psychoactive drugs, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Bibliometric Analysis of Academic Journal Articles Reporting Results of Psychedelic Clinical Studies. - Weleff J; Akiki TJ; Barnett BS (Journal of psychoactive drugs, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

An Assessment of Psychedelic Knowledge Among People Using Psychedelics Naturalistically. - Kruger DJ; Glynos NG; Fields CW; Herberholz M; Boehnke KF (Journal of psychoactive drugs, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

History of the administration of psychedelics in France. - Dubus Z; Grandgeorge E; Verroust V (Frontiers in psychology, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Self-administration of Psilocybin for the Acute Treatment of Migraine: A Case Report. - Lawrence DW (Innovations in clinical neuroscience, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Psychedelics for treatment resistant depression: are they game changers? - Kalfas M; Taylor RH; Tsapekos D; Young AH (Expert opinion on pharmacotherapy, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Nature-themed video intervention may improve cardiovascular safety of psilocybin-assisted therapy for alcohol use disorder. - Heinzerling KG; Sergi K; Linton M; Rich R; Youssef B; Bentancourt I; Bramen J; Siddarth P; Schwartzberg L; Kelly DF (Frontiers in psychiatry, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Naturalistic psilocybin use is associated with persisting improvements in mental health and wellbeing: results from a prospective, longitudinal survey. - Nayak SM; Jackson H; Sepeda ND; Mathai DS; So S; Yaffe A; Zaki H; Brasher TJ; Lowe MX; Jolly DRP; Barrett FS; Griffiths RR; et al. (Frontiers in psychiatry, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Lifeboat ethics, risk, and therapeutic opportunity: an appeal for equitable psychedelic therapy access in the "high-risk" addiction patient. - Black T (Frontiers in psychiatry, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Manic episode following psilocybin use in a man with bipolar II disorder: a case report. - Halim HJ; Burk BG; Fargason RE; Birur B (Frontiers in psychiatry, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Bedside to bench: the outlook for psychedelic research. - Acero VP; Cribas ES; Browne KD; Rivellini O; Burrell JC; O'Donnell JC; Das S; Cullen DK (Frontiers in pharmacology, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Predicting the Intensity of Psychedelic-Induced Mystical and Challenging Experience in a Healthy Population: An Exploratory Post-Hoc Analysis. - Ko K; Carter B; Cleare AJ; Rucker JJ (Neuropsychiatric disease and treatment, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Editorial: Psychedelics as treatments for substance use disorders: exploring therapeutic potential, risks, underlying mechanisms of action, and implementation challenges. - Barnett BS; Bassir Nia A; Sackett NB; Weleff J (Frontiers in psychiatry, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Psychedelic Treatments for Substance Use Disorder and Substance Misuse: A Mixed Methods Systematic Review. - Sharma R; Batchelor R; Sin J (Journal of psychoactive drugs, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

"How Do I Learn More About this?": Utilization and Trust of Psychedelic Information Sources Among People Naturalistically Using Psychedelics. - Kruger DJ; Enghoff O; Herberholz M; Barron J; Boehnke KF (Journal of psychoactive drugs, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

A Proposal to Study the Safety and Efficacy of in Preclinical and Clinical Studies as a Therapeutic Alternative for Major Depressive Disorder. - Escamilla R; González-Trujano ME; González Mariscal JM; Torres-Valencia JM; Guzmán-González H; Vega JL; Loizaga-Velder A (Journal of psychoactive drugs, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Three Cases of Reported Improvement in Microsmia and Anosmia Following Naturalistic Use of Psilocybin and LSD. - Kovacevich A; Weleff J; Claytor B; Barnett BS (Journal of psychoactive drugs, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Epidemiology of classic psychedelic substances: results from a Norwegian internet convenience sample. - Kvam TM; Uthaug MV; Andersen KAA; Refsum BB; Tunstad PA; Stewart LH; Jacobsen HB; Grønnerød C (Frontiers in psychiatry, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Biological studies of clavine alkaloids targeting CNS receptors. - Tasker NR; Pazur EJ; Wipf P (Frontiers in psychiatry, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Exploring spp. mycelium and fruiting body chemistry for potential therapeutic compounds. - Waldbillig A; Baranova M; Neumann S; Andrade J; Sidhu S (Frontiers in fungal biology, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Group psychedelic therapy: empirical estimates of cost-savings and improved access. - Marseille E; Stauffer CS; Agrawal M; Thambi P; Roddy K; Mithoefer M; Bertozzi SM; Kahn JG (Frontiers in psychiatry, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Safety, feasibility, tolerability, and clinical effects of repeated psilocybin dosing combined with non-directive support in the treatment of obsessive-compulsive disorder: protocol for a randomized, waitlist-controlled trial with blinded ratings. - Ching THW; Amoroso L; Bohner C; D'Amico E; Eilbott J; Entezar T; Fitzpatrick M; Fram G; Grazioplene R; Hokanson J; Kichuk SA; Martins B; et al. (Frontiers in psychiatry, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Psychedelics, epilepsy, and seizures: a review. - Freidel N; Kreuder L; Rabinovitch BS; Chen FY; Huang RST; Lewis EC (Frontiers in pharmacology, 2023)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Ego Birth: Measure 109, The NMHA, and Forward Movement in the Nascent Psilocybin Industry - Andrew M. Robie (SSRN Electronic Journal, 2022)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

From prohibited to prescribed: The rescheduling of MDMA and psilocybin in Australia - Octavian Dixon Ritchie; Cameron N Donley; Gabrielle Dixon Ritchie (Drug Science Policy and Law, 2022)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Psilocybin for Depression: From Credibility to Feasibility, What's Missing? - Munafò A; Arillotta D; Mannaioni G; Schifano F; Bernardini R; Cantarella G (Pharmaceuticals (Basel, Switzerland), 2022)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

The Potential of Psilocybe Genus Fungi to Treat Depression and Some Addictions - Vanessa Eveline VLAIC; Andreea ONA (Hop and Medicinal Plants, 2022)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

A Review of Synthetic Access to Therapeutic Compounds Extracted from. - Serreau R; Amirouche A; Benyamina A; Berteina-Raboin S (Pharmaceuticals (Basel, Switzerland), 2022)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Depression Improves Following Single Dose of Psilocybin - Nick Zagorski (Psychiatric News, 2022)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

DNA Authentication and Chemical Analysis of Mushrooms Reveal Widespread Misdeterminations in Fungaria and Inconsistencies in Metabolites. - Bradshaw AJ; Backman TA; Ramírez-Cruz V; Forrister DL; Winter JM; Guzmán-Dávalos L; Furci G; Stamets P; Dentinger BTM (Applied and environmental microbiology, 2022)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Associations between MDMA/ecstasy, classic psychedelics, and suicidal thoughts and behaviors in a sample of U.S. adolescents. - Jones G; Arias D; Nock M (Scientific reports, 2022)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

High time? Psychedelics on cannabis-like fast track to legalization - Kevin Zannese (Canadian Medical Association Journal, 2022)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Characterization of the Gateway Decarboxylase for Psilocybin Biosynthesis. - Schäfer T; Kramer K; Werten S; Rupp B; Hoffmeister D (Chembiochem: a European journal of chemical biology, 2022)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Phylogenomics of the psychoactive mushroom genus Psilocybe and evolution of the psilocybin biosynthetic gene cluster - Bradshaw AJ; Ramírez-Cruz V; Awan AR; Furci G; Guzmán-Dávalos L; Stamets P; Dentinger BT. (bioRxiv, 2022)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Effects of a single dose of psilocybin on cytokines, chemokines and leptin in rat serum - Geoffrey M. Bove; David J. Mokler (Journal of Psychedelic Studies, 2022)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Psychedelic-Induced Serotonin 2A Receptor Downregulation Does Not Predict Swim Stress Coping in Mice. - Pędzich BD; Medrano M; Buckinx A; Smolders I; De Bundel D (International journal of molecular sciences, 2022)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Direct Quantitation of Psilocybin and Psilocin by One-Dimensional 1H and 31P qNMR in a revived Greek specimen of Psilocybe cyanescens - Magiatis P; Dadiotis E; Antonopoulos R K; Ioannidis K; Mitsis V; Melliou E; Gonou-Zagou Z (Planta Medica, 2022)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

The psychedelic renaissance: the next trip for psychiatry? - Kelly JR; Baker A; Babiker M; Burke L; Brennan C; O'Keane V (Irish journal of psychological medicine, 2022)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Use of plant-based hallucinogens and dissociative agents: U.S. Time Trends, 2002-2019. - Walsh CA; Livne O; Shmulewitz D; Stohl M; Hasin DS (Addictive behaviors reports, 2022)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Set and setting in microdosing: an oft-overlooked principle. - Hartogsohn I; Petranker R (Psychopharmacology, 2022)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Psilocybin for alcohol use disorder: Rationale and design considerations for a randomized controlled trial. - O'Donnell KC; Mennenga SE; Owens LT; Podrebarac SK; Baron T; Rotrosen J; Ross S; Forcehimes AA; Bogenschutz MP (Contemporary clinical trials, 2022)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Psilocybin containing mushrooms: a rapidly developing biotechnology industry in the psychiatry, biomedical and nutraceutical fields. - Strauss D; Ghosh S; Murray Z; Gryzenhout M (3 Biotech, 2022)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Psilocybin modulation of time-varying functional connectivity is associated with plasma psilocin and subjective effects - Olsen Anders S.; Lykkebo-Valløe Anders; Ozenne Brice; Madsen Martin K.; Stenbæk Dea S.; Armand Sophia; Mørup Morten; Ganz Melanie; Knudsen Gitte M.; Fisher Patrick M. (NeuroImage, 2022)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Psychedelic-Assisted Therapy for People with Eating Disorders. - Gukasyan N; Schreyer CC; Griffiths RR; Guarda AS (Current psychiatry reports, 2022)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

A Case of Prolonged Mania, Psychosis, and Severe Depression After Psilocybin Use: Implications of Increased Psychedelic Drug Availability. - Barber G; Nemeroff CB; Siegel S (The American journal of psychiatry, 2022)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Single-dose psilocybin for treatment-resistant obsessive-compulsive disorder: A case report. - Kelmendi B; Kichuk SA; DePalmer G; Maloney G; Ching THW; Belser A; Pittenger C (Heliyon, 2022)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Antidepressant properties of psilocybin might be related to changes in sleep - Dooper Marten (Medicom Conference Report ECNP 2022, 2022)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Fast and sustained effect of 2 administrations of psilocybin on depression - Dooper Marten (Medicom Conference Report ECNP 2022, 2022)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Mode of action of psilocybin - Dooper Marten (Medicom Conference Report ECNP 2022, 2022)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

NW Trauma Therapies, Chronic Illness of Chronic Depression, PTSD, MS, HIV, and SARS-CoV-2, Long Haulers Syndrome. Treatment of Unregulaaible Trauma by the Treatment of Enhanced Micro Dosing the Levels of 0.15, Thru 0.33, With a Maintenance Dose of 1 Gram Per Month for Neural Pathway Increase of Non Synthesized Psilocybin, Using the Actual Plant to Regulate the Highjacked Nervous System. - NWTraumatherapies (ClinicalTrials.gov, 2022)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Role of 5-HT2A, 5-HT2C, 5-HT1A and TAAR1 Receptors in the Head Twitch Response Induced by 5-Hydroxytryptophan and Psilocybin: Translational Implications. - Shahar O; Botvinnik A; Esh-Zuntz N; Brownstien M; Wolf R; Lotan A; Wolf G; Lerer B; Lifschytz T (International journal of molecular sciences, 2022)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Manuel de Yale pour la Thérapie de la Dépression Assistée par la Psilocybine - Guss J; Krause R; Sloshower J. (PsyArXiv, 2022)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Manuel de Yale pour la Thérapie de la Dépression Assistée par la Psilocybine - Jeffrey Guss; Robert Krause; Jordan Sloshower (PsyArXiv, 2022)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Psychedelic compounds directly excite 5-HT2A Layer 5 Pyramidal Neurons in the Prefrontal Cortex through a 5-HT2A Gq -mediated activation mechanism - Schmitz GP; Chiu Y; König GM; Kostenis E; Roth BL; Herman MA. (bioRxiv, 2022)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Policy considerations that support equitable access to responsible, accountable, safe, and ethical uses of psychedelic medicines. - Belouin SJ; Averill LA; Henningfield JE; Xenakis SN; Donato I; Grob CS; Berger A; Magar V; Danforth AL; Anderson BT (Neuropharmacology, 2022)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Extensive Collection of Psychotropic Mushrooms with Determination of Their Tryptamine Alkaloids. - Gotvaldová K; Borovička J; Hájková K; Cihlářová P; Rockefeller A; Kuchař M (International journal of molecular sciences, 2022)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Structure-Activity Relationships for Psilocybin, Baeocystin, Aeruginascin, and Related Analogues to Produce Pharmacological Effects in Mice. - Glatfelter GC; Pottie E; Partilla JS; Sherwood AM; Kaylo K; Pham DNK; Naeem M; Sammeta VR; DeBoer S; Golen JA; Hulley EB; Stove CP; et al. (ACS pharmacology & translational science, 2022)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

A Double-Blind Trial of Psilocybin-Assisted Treatment of Alcohol Dependence - NYU Langone Health (ClinicalTrials.gov, 2022)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Experts assess role of therapists in psychedelic-assisted therapy - Valerie A. Canady (Mental Health Weekly, 2022)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

5-MeO-DMT modifies innate behaviors and promotes structural neural plasticity in mice - Jefferson SJ; Gregg I; Dibbs M; Liao C; Wu H; Davoudian PA; Sprouse JS; Sherwood AM; Kaye AP; Pittenger C; Kwan AC. (bioRxiv, 2022)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression. - Goodwin GM; Aaronson ST; Alvarez O; Arden PC; Baker A; Bennett JC; Bird C; Blom RE; Brennan C; Brusch D; Burke L; Campbell-Coker K; et al. (The New England journal of medicine, 2022)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Psilocybin in Treatment-Resistant Depression. - Madras BK (The New England journal of medicine, 2022)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com

Psilocybin reduces symptoms in treatment resistant depression, trial results show. - Iacobucci G (BMJ (Clinical research ed.), 2022)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com